2024-10-31 01:30:32
Chipscreen received a Phase 1b/2 clinical trial of Chiauranib/CS2164 IND clearance from the US Food and Drug Administration (FDA)
Corporate/ 2023-07-23
Chipscreen received a Phase 1b/2 clinica...

SHENZHEN,China,April 16,2021--Shenzhen Chipscreen Biosciences,a China headquartered biopharmaceutical company developing and marketing novel...

Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide
Corporate/ 2023-07-23
Kintor Pharmaceuticals Announced Success...

SUZHOU,China,April 16,2021-- Kintor Pharmaceutical Limited (HKEX: 9939),a clinical-stage biotechnology company developing small molecule and...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release